-
2
-
-
0033134958
-
Significance of chronic transplant nephropathy on early protocol biopsies for graft outcome in pediatric renal transplantation
-
Fujisawa M, Ono H, Isotani S, et al., Significance of chronic transplant nephropathy on early protocol biopsies for graft outcome in pediatric renal transplantation. Transplant Proc 1999: 31: 1687-1690.
-
(1999)
Transplant Proc
, vol.31
, pp. 1687-1690
-
-
Fujisawa, M.1
Ono, H.2
Isotani, S.3
-
3
-
-
0026558834
-
Histopathologic findings in well-functioning, long-term renal allografts
-
Isoniemi HM, Krogerus L, Von Willebrand E, et al., Histopathologic findings in well-functioning, long-term renal allografts. Kidney Int 1992: 41: 155-160.
-
(1992)
Kidney Int
, vol.41
, pp. 155-160
-
-
Isoniemi, H.M.1
Krogerus, L.2
Von Willebrand, E.3
-
4
-
-
33744796811
-
Predictors of chronic allograft nephropathy from protocol biopsies using histological and immunohistochemical techniques
-
Mehia M, Matheson PJ, Merrilees MJ, et al., Predictors of chronic allograft nephropathy from protocol biopsies using histological and immunohistochemical techniques. Nephrology (Carlton) 2006: 11: 261-266.
-
(2006)
Nephrology (Carlton)
, vol.11
, pp. 261-266
-
-
Mehia, M.1
Matheson, P.J.2
Merrilees, M.J.3
-
5
-
-
10944268996
-
Risk factors for chronic allograft nephropathy after renal transplantation: A protocol biopsy study
-
Schwarz A, Mengel M, Gwinner W, et al., Risk factors for chronic allograft nephropathy after renal transplantation: A protocol biopsy study. Kidney Int 2005: 67: 341-348.
-
(2005)
Kidney Int
, vol.67
, pp. 341-348
-
-
Schwarz, A.1
Mengel, M.2
Gwinner, W.3
-
7
-
-
33646384606
-
Monoclonal and polyclonal antibody therapy for treating acute rejection in kidney transplant recipients: A systematic review of randomized trial data
-
Webster AC, Pankhurst T, Rinaldi F, et al., Monoclonal and polyclonal antibody therapy for treating acute rejection in kidney transplant recipients: A systematic review of randomized trial data. Transplantation 2006: 81: 953-965.
-
(2006)
Transplantation
, vol.81
, pp. 953-965
-
-
Webster, A.C.1
Pankhurst, T.2
Rinaldi, F.3
-
8
-
-
0032490341
-
Prope tolerance, perioperative Campath-1H, and low-dose cyclosporin monotherapy in renal allograft recipients
-
Calne R, Friend P, Moffatt S, et al., Prope tolerance, perioperative Campath-1H, and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet 1998: 351: 1701-1702.
-
(1998)
Lancet
, vol.351
, pp. 1701-1702
-
-
Calne, R.1
Friend, P.2
Moffatt, S.3
-
9
-
-
1942454828
-
Present experience with Campath-1H in organ transplantation and its potential use in pediatric recipients
-
Knechtle SJ,. Present experience with Campath-1H in organ transplantation and its potential use in pediatric recipients. Pediatr Transplant 2004: 8: 106-112.
-
(2004)
Pediatr Transplant
, vol.8
, pp. 106-112
-
-
Knechtle, S.J.1
-
10
-
-
20544458513
-
Alemtuzumab (Campath-1H) induction therapy in cadaveric kidney transplantationâEfficacy and safety at five years
-
Watson CJ, Bradley JA, Friend PJ, et al., Alemtuzumab (Campath-1H) induction therapy in cadaveric kidney transplantationâEfficacy and safety at five years. Am J Transplant 2005: 5: 1347.
-
(2005)
Am J Transplant
, vol.5
, pp. 1347
-
-
Watson, C.J.1
Bradley, J.A.2
Friend, P.J.3
-
11
-
-
67649603468
-
Alemtuzumab as induction therapy in renal transplantation
-
Clatworthy MR, Watson CJE,. Alemtuzumab as induction therapy in renal transplantation. Trends Transplant 2008: 2: 12.
-
(2008)
Trends Transplant
, vol.2
, pp. 12
-
-
Clatworthy, M.R.1
Watson, C.J.E.2
-
12
-
-
58849135828
-
Pediatric living donor kidney transplantation under alemtuzumab pretreatment and tacrolimus monotherapy: 4 year experience
-
Tan H, Donaldson J, Ellis D, et al., Pediatric living donor kidney transplantation under alemtuzumab pretreatment and tacrolimus monotherapy: 4 year experience. Transplantation 2008: 86: 1725-1731.
-
(2008)
Transplantation
, vol.86
, pp. 1725-1731
-
-
Tan, H.1
Donaldson, J.2
Ellis, D.3
-
13
-
-
0028800590
-
Successful treatment of renal allograft rejection with a humanized antilymphocyte monoclonal antibody
-
Friend PJ, Rebello P, Oliveira D, et al., Successful treatment of renal allograft rejection with a humanized antilymphocyte monoclonal antibody. Transplant Proc 1995: 27: 869.
-
(1995)
Transplant Proc
, vol.27
, pp. 869
-
-
Friend, P.J.1
Rebello, P.2
Oliveira, D.3
-
15
-
-
21844454963
-
Campath-1H as rescue therapy for the treatment of acute rejection in kidney transplant patients
-
Csapo Z, Benavides-Viveros C, Podder H, et al., Campath-1H as rescue therapy for the treatment of acute rejection in kidney transplant patients. Transplant Proc 2005: 37: 2032.
-
(2005)
Transplant Proc
, vol.37
, pp. 2032
-
-
Csapo, Z.1
Benavides-Viveros, C.2
Podder, H.3
-
16
-
-
65549147185
-
Alemtuzumab (Campath-1H) for the treatment of acute rejection in kidney transplant recipients: Long-term follow-up
-
Clatworthy MR, Friend PJ, Calne RY, et al., Alemtuzumab (Campath-1H) for the treatment of acute rejection in kidney transplant recipients: long-term follow-up. Transplantation 2009: 87: 1092-1095.
-
(2009)
Transplantation
, vol.87
, pp. 1092-1095
-
-
Clatworthy, M.R.1
Friend, P.J.2
Calne, R.Y.3
-
17
-
-
17844363736
-
Reversal of acute cellular rejection after renal transplantation with Campath-1H
-
Basu A, Ramkumar M, Tan HP, et al., Reversal of acute cellular rejection after renal transplantation with Campath-1H. Transplant Proc 2005: 37: 923.
-
(2005)
Transplant Proc
, vol.37
, pp. 923
-
-
Basu, A.1
Ramkumar, M.2
Tan, H.P.3
-
19
-
-
40449101372
-
Banff 07 classification or renal allograft pathology: Updates and future directions
-
Solez K, Colvin RB, Racusen LC, et al., Banff 07 classification or renal allograft pathology: Updates and future directions. Am J Transplant 2008: 8: 753-776.
-
(2008)
Am J Transplant
, vol.8
, pp. 753-776
-
-
Solez, K.1
Colvin, R.B.2
Racusen, L.C.3
-
20
-
-
0035140912
-
Steroid-resistant kidney transplant rejection: Diagnosis and treatment
-
Bock HA,. Steroid-resistant kidney transplant rejection: Diagnosis and treatment. J Am Soc Nephrol 2001: 17: s48-s52.
-
(2001)
J Am Soc Nephrol
, vol.17
-
-
Bock, H.A.1
-
21
-
-
70350131763
-
De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure
-
Hidalgo LG, Campbell PM, Sis B, et al., De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant 2009: 9: 2532-2541.
-
(2009)
Am J Transplant
, vol.9
, pp. 2532-2541
-
-
Hidalgo, L.G.1
Campbell, P.M.2
Sis, B.3
-
22
-
-
0024383936
-
Low-dose vs high-dose intravenous methylprednisolone therapy for acute renal allograft rejection in patients receiving cyclosporin therapy
-
Lui SF, Sweny P, Scoble JE, et al., Low-dose vs high-dose intravenous methylprednisolone therapy for acute renal allograft rejection in patients receiving cyclosporin therapy. Nephrol Dial Transplant 1989: 4: 387-389.
-
(1989)
Nephrol Dial Transplant
, vol.4
, pp. 387-389
-
-
Lui, S.F.1
Sweny, P.2
Scoble, J.E.3
-
23
-
-
0021816056
-
A randomized trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants
-
O rtho M ulticenter T ransplant S tudy G roup
-
O rtho M ulticenter T ransplant S tudy G roup. A randomized trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants. N Engl J Med 1985: 313: 337-342.
-
(1985)
N Engl J Med
, vol.313
, pp. 337-342
-
-
-
24
-
-
0345676502
-
Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation
-
Gaber AO, First MR, Tesi RJ, et al., Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation. Transplantation 1998: 66: 29.
-
(1998)
Transplantation
, vol.66
, pp. 29
-
-
Gaber, A.O.1
First, M.R.2
Tesi, R.J.3
-
25
-
-
67650651210
-
Successful rescue of late-onset acute T-cell mediated rejection with anti-CD25 antibody: A case report
-
Osawa T, Harada H, Miura M, et al., Successful rescue of late-onset acute T-cell mediated rejection with anti-CD25 antibody: A case report. Clin Transplant 2009: 23 (Suppl 20): 31-33.
-
(2009)
Clin Transplant
, vol.23
, Issue.SUPPL. 20
, pp. 31-33
-
-
Osawa, T.1
Harada, H.2
Miura, M.3
-
26
-
-
28444460281
-
Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: A literature review
-
Denhaerynck K, Dobbels F, Cleemput I, et al., Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: A literature review. Transpl Int 2005: 18: 1121-1133.
-
(2005)
Transpl Int
, vol.18
, pp. 1121-1133
-
-
Denhaerynck, K.1
Dobbels, F.2
Cleemput, I.3
-
27
-
-
0028569493
-
Late-acute renal allograft rejection and symptomless cytomegalovirus infection
-
Reinke P, Lippert J, Ewert R, et al., Late-acute renal allograft rejection and symptomless cytomegalovirus infection. Lancet 1994: 344: 1737-1738.
-
(1994)
Lancet
, vol.344
, pp. 1737-1738
-
-
Reinke, P.1
Lippert, J.2
Ewert, R.3
-
28
-
-
0035959321
-
Association between Epstein-barr virus infection and late acute rejection in long-term transplant patients
-
Babel N, Schwarzmann F, Prang N, et al., Association between Epstein-barr virus infection and late acute rejection in long-term transplant patients. Transplantation 2001: 72: 736-739.
-
(2001)
Transplantation
, vol.72
, pp. 736-739
-
-
Babel, N.1
Schwarzmann, F.2
Prang, N.3
-
29
-
-
0037467793
-
Early versus late acute rejection episodes in renal transplantation
-
Sijpkens Y, Doxiadis I, Mallat M, et al., Early versus late acute rejection episodes in renal transplantation. Transplantation 2003: 75: 204-208.
-
(2003)
Transplantation
, vol.75
, pp. 204-208
-
-
Sijpkens, Y.1
Doxiadis, I.2
Mallat, M.3
-
30
-
-
0013005599
-
HLA class i residue mismatch and renal graft outcome
-
Piazza A, Canossi A, Buonomo O, et al., HLA class I residue mismatch and renal graft outcome. Transpl Int 2000: 13 (Suppl 1): S444-S448.
-
(2000)
Transpl Int
, vol.13
, Issue.SUPPL. 1
-
-
Piazza, A.1
Canossi, A.2
Buonomo, O.3
-
31
-
-
67650475370
-
Melatonin - A pleotropic molecule involved in pathophysiological processes following organ transplantation
-
Fildes JE, Yonan N, Keevil BG, et al., Melatonin-a pleotropic molecule involved in pathophysiological processes following organ transplantation. Immunology 2009: 127: 443-449.
-
(2009)
Immunology
, vol.127
, pp. 443-449
-
-
Fildes, J.E.1
Yonan, N.2
Keevil, B.G.3
-
32
-
-
71249107177
-
Late acute kidney transplant rejection: Clinicopathological correlates and response to corticosteroid therapy
-
Nair R, Agrawal N, Lebaeau M, et al., Late acute kidney transplant rejection: Clinicopathological correlates and response to corticosteroid therapy. Transplant Proc 2009: 41: 4150-4153.
-
(2009)
Transplant Proc
, vol.41
, pp. 4150-4153
-
-
Nair, R.1
Agrawal, N.2
Lebaeau, M.3
-
33
-
-
33746168208
-
Late and early C4d-positive acute rejection: Different clinico-histopathological subentities in renal transplantation
-
Sun Q, Liu ZH, Ji S, et al., Late and early C4d-positive acute rejection: Different clinico-histopathological subentities in renal transplantation. Kidney Int 2006: 70: 377-383.
-
(2006)
Kidney Int
, vol.70
, pp. 377-383
-
-
Sun, Q.1
Liu, Z.H.2
Ji, S.3
-
34
-
-
79954435397
-
Antithymocyte treatment of steroid-resistant acute rejection in renal transplantation
-
Shenoy M, Roberts D, Plant ND, et al., Antithymocyte treatment of steroid-resistant acute rejection in renal transplantation. Pediatr Nephrol 2011: 26: 815-818.
-
(2011)
Pediatr Nephrol
, vol.26
, pp. 815-818
-
-
Shenoy, M.1
Roberts, D.2
Plant, N.D.3
-
35
-
-
58849136282
-
Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection
-
Everly MJ, Everly JJ, Susskind B, et al., Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection. Transplantation 2008: 86: 1754.
-
(2008)
Transplantation
, vol.86
, pp. 1754
-
-
Everly, M.J.1
Everly, J.J.2
Susskind, B.3
-
36
-
-
0032914706
-
Anti-lymphocyte antibodies late in the course of pediatric renal transplantation
-
Butani L, Polinsky MS, Kaiser BA, et al., Anti-lymphocyte antibodies late in the course of pediatric renal transplantation. Pediatr Nephrol 1999: 13: 192-194.
-
(1999)
Pediatr Nephrol
, vol.13
, pp. 192-194
-
-
Butani, L.1
Polinsky, M.S.2
Kaiser, B.A.3
-
37
-
-
0032846748
-
Sensitization following Thymoglobulin and Atgam rejection therapy as determined with a rapid enzyme-linked immunosorbent assay. US Thymoglobulin Multi-center Study Group
-
Regan JF, Campbell K, Van Smith L, et al., Sensitization following Thymoglobulin and Atgam rejection therapy as determined with a rapid enzyme-linked immunosorbent assay. US Thymoglobulin Multi-center Study Group. Transpl Immunol 1999: 7: 115-121.
-
(1999)
Transpl Immunol
, vol.7
, pp. 115-121
-
-
Regan, J.F.1
Campbell, K.2
Van Smith, L.3
-
38
-
-
0035881990
-
Reversal of steroid- and anti-lymphocyte antibody-resistant rejection using intravenous immunoglobulin in renal transplant recipients
-
Luke PW, Scantlebury VP, Jordan ML, et al., Reversal of steroid- and anti-lymphocyte antibody-resistant rejection using intravenous immunoglobulin in renal transplant recipients. Transplantation 2001: 72: 419-422.
-
(2001)
Transplantation
, vol.72
, pp. 419-422
-
-
Luke, P.W.1
Scantlebury, V.P.2
Jordan, M.L.3
-
39
-
-
68849105740
-
Role of NK and NKT cells in solid organ transplantation
-
Pratschke J, Stauch D, Kotsch K,. Role of NK and NKT cells in solid organ transplantation. Transpl Int 2009: 22: 859-868.
-
(2009)
Transpl Int
, vol.22
, pp. 859-868
-
-
Pratschke, J.1
Stauch, D.2
Kotsch, K.3
-
40
-
-
65549090058
-
Targeting of Natural Killer cells by rabbit antithymocyte globulin and Campath- 1H: Similar effects independent of specificity
-
Stauch D, Dernier A, Volk HDD, et al., Targeting of Natural Killer cells by rabbit antithymocyte globulin and Campath- 1H: Similar effects independent of specificity. PLoS ONE 2009: 4: e4709.
-
(2009)
PLoS ONE
, vol.4
-
-
Stauch, D.1
Dernier, A.2
Volk, H.D.D.3
|